retatrutide weight loss phase 2 trial results Retatrutide: The Triple Agonist That's Redrawing the Map of Obesity Medicine When Will Retatrutide Be FDA

The FDA says state-licensed compounding pharmacies must immediately stop making most compound versions of GLP-1 drugs based on tirzepatide

PubMed, Holt, Marie K., et al

This is especially critical for diabetic patients who are at an increased risk of cardiac diseases

This gradual increase minimizes side effects while allowing your body to adjust

The strategy for you includes: Load the Body: If you are on a weight-loss journey, resistance training should be your top priority to signal the body to retain its muscle

Call us today or submit a contact form online to learn more about how our weight loss injection program in San Diego can help you on your weight loss journey